Detalhe da pesquisa
1.
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
Int J Mol Sci
; 23(10)2022 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628286
2.
Does hemofiltration protect the brain after head trauma? An experimental study in rabbits.
Intensive Care Med Exp
; 8(1): 66, 2020 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33206250
3.
Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer.
Cancer Lett
; 491: 50-59, 2020 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735909
4.
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.
J Exp Clin Cancer Res
; 38(1): 383, 2019 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470872
5.
Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models.
ACS Omega
; 4(8): 13005-13014, 2019 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31460427
6.
Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer.
Oncotarget
; 6(29): 27923-37, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26314846